Bullisch
$8.88
Szenariopreis
$12.520
+0.203 (+1.62%)Zum Schluss
LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 8,300 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.
LifeStance Health Group Inc is a good buy right now, trading at $12.42 with a strong year-to-date change of +78.45% and a one-year change of +143.05%. The RSI is at 66.39, indicating strong momentum, while the forward P/E ratio of 52.63 suggests growth potential. The main risk is the insider selling, with the CTO selling 42,067 shares, which could indicate profit-taking, but he still retains a significant stake worth $2.6 million.
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

LifeStance Health Group CTO Sells Shares Amid Strong Stock Performance

LifeStance Executive Share Disposition Analysis

OBIO and LFST Stocks Hit New Highs Amid Positive Analyst Sentiment

LifeStance Health Group Announces Secondary Public Offering

LifeStance Health Surpasses Q2 Earnings Expectations Driven by Clinician Growth
LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 8,300 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).
LifeStance Health Group Inc is a good buy right now, trading at $12.42 with a strong year-to-date change of +78.45% and a one-year change of +143.05%. The RSI is at 66.39, indicating strong momentum, while the forward P/E ratio of 52.63 suggests growth potential. The main risk is the insider selling, with the CTO selling 42,067 shares, which could indicate profit-taking, but he still retains a significant stake worth $2.6 million.
Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.